Form 4: Abeona Therapeutics SVP, General Counsel Brendan O'Malley Reports Stock Transaction
SEC Form 4 Filing
Brendan O'Malley, SVP and General Counsel of Abeona Therapeutics, reported the disposition of 183 shares of common stock to cover tax obligations upon vesting of restricted stock on March 4, 2024.
Summary
- On March 4, 2024, Brendan O'Malley, the SVP and General Counsel of Abeona Therapeutics, reported a transaction involving the company's stock.
- O'Malley disposed of 183 shares of common stock to satisfy tax withholding obligations related to the vesting of restricted stock.
- The transaction was executed at a price of $7.81 per share.
- Following the transaction, O'Malley directly owns 180,118 shares of Abeona Therapeutics common stock.
Sentiment
Score: 5
Explanation: This is a neutral report of a routine stock transaction. It doesn't indicate positive or negative sentiment about the company's performance.
Industry Context
This is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it involves a small number of shares.
Key Dates
| Date | Description |
|---|---|
| 03/04/2024 | Date of stock transaction (disposal of shares). |
| 03/12/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.